GRI Bio GRI
NASDAQ GRI
$1.45 +0.03 (+2.11%)
At close: Oct 23, 2026 · 4:00 PM EDT

GRI Bio (GRI) EBITDA Margin (2023 - 2026)

Updated

GRI Bio (GRI) posted EBITDA Margin of -4714.00% for FY2020.

Analysis

GRI Bio (GRI) EBITDA Margin (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 32.68%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 49.01%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 6.02%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 33.11%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 46.01%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -124.26%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 39.16%
10 GRI Bio 2.62 Mn -31.66 Mn - -32,960.00%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -32,960.00%
Mar 31, 2026 -40,040.00%
Dec 31, 2025 -53,260.00%
Sep 30, 2025 -56,066.67%
Jun 30, 2025 -57,920.00%
Mar 31, 2025 -61,000.00%
Dec 31, 2024 -32,550.00%
Sep 30, 2024 -30,414.29%
Jun 30, 2024 -37,600.00%
Mar 31, 2024 -31,566.67%
Dec 31, 2023 -28,928.57%
Sep 30, 2023 -40,633.33%
API Access

GRI Bio EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=GRI&period=max&api_key=YOUR_API_KEY